Jan E. Ehlert

2.8k total citations · 1 hit paper
27 papers, 2.1k citations indexed

About

Jan E. Ehlert is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jan E. Ehlert has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Jan E. Ehlert's work include Chemokine receptors and signaling (8 papers), Cell Adhesion Molecules Research (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Jan E. Ehlert is often cited by papers focused on Chemokine receptors and signaling (8 papers), Cell Adhesion Molecules Research (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Jan E. Ehlert collaborates with scholars based in Germany, United States and Switzerland. Jan E. Ehlert's co-authors include Robert M. Strieter, Marie D. Burdick, Christina Addison, John A. Belperio, Douglas A. Arenberg, Michael P. Keane, Ernst Brandt, Hua Liu, Thomas O. Daniel and Ann Richmond and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Jan E. Ehlert

25 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CXC chemokines in angiogenesis

2000 655 citations John A. Belperio, Michael P. Keane et al. Journal of Leukocyte Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan E. Ehlert Germany	14	970	896	587	296	190	27	2.1k
Arlene J. Hoogewerf United States	17	1.3k 1.3×	1.3k 1.5×	897 1.5×	546 1.8×	135 0.7×	21	2.8k
Ido D. Weiss United States	30	977 1.0×	1.0k 1.1×	568 1.0×	159 0.5×	293 1.5×	48	2.3k
H.L.S. Wong United States	22	451 0.5×	864 1.0×	757 1.3×	290 1.0×	111 0.6×	50	2.3k
Lars Uhlin‐Hansen Norway	27	688 0.7×	575 0.6×	1.1k 1.9×	224 0.8×	239 1.3×	56	2.5k
Anneleen Mortier Belgium	26	836 0.9×	757 0.8×	499 0.9×	285 1.0×	60 0.3×	42	1.9k
Gary C. Starling United States	28	658 0.7×	1.6k 1.8×	894 1.5×	180 0.6×	417 2.2×	59	2.6k
J Bréard France	17	383 0.4×	1.3k 1.5×	756 1.3×	237 0.8×	448 2.4×	22	2.9k
Wilfred W. Raymond United States	21	394 0.4×	1.1k 1.3×	803 1.4×	407 1.4×	130 0.7×	37	2.2k
Jennifer H. Cox Canada	21	715 0.7×	816 0.9×	625 1.1×	151 0.5×	187 1.0×	29	2.0k
Takashi Tanaka Japan	10	679 0.7×	1.2k 1.3×	606 1.0×	105 0.4×	88 0.5×	11	2.1k

Countries citing papers authored by Jan E. Ehlert

Since Specialization

Citations

This map shows the geographic impact of Jan E. Ehlert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan E. Ehlert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan E. Ehlert more than expected).

Fields of papers citing papers by Jan E. Ehlert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan E. Ehlert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan E. Ehlert. The network helps show where Jan E. Ehlert may publish in the future.

Co-authorship network of co-authors of Jan E. Ehlert

This figure shows the co-authorship network connecting the top 25 collaborators of Jan E. Ehlert. A scholar is included among the top collaborators of Jan E. Ehlert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan E. Ehlert. Jan E. Ehlert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Metzger, Philipp, et al.. (2025). Abstract 2891: In vitro comparison of Kadcyla and Enhertu in breast cancer with varying HER2 expression: proliferation, internalization, bystander effects and toxicity. Cancer Research. 85(8_Supplement_1). 2891–2891.

Feger, Daniel, et al.. (2023). Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line. Discover Oncology. 14(1). 27–27. 4 indexed citations

Feger, Daniel, et al.. (2023). Abstract 549: Characterization of the selective inhibitory effect of KRas inhibitors in different cellular assay formats. Cancer Research. 83(7_Supplement). 549–549. 1 indexed citations

Ehlert, Jan E., et al.. (2022). Abstract 2318: Real-time quantitative PCR based analysis of transcriptional effects of CDK8/Cyclin C inhibitors. Cancer Research. 82(12_Supplement). 2318–2318. 1 indexed citations

Weber, Christian, et al.. (2022). Abstract 4072: Cytotoxic effects of LRRK2 inhibitors in combined treatment with chemotherapeutic agents on a large panel of cancer cell lines. Cancer Research. 82(12_Supplement). 4072–4072. 1 indexed citations

Berrou, Jeannig, Jan E. Ehlert, Holger Weber, et al.. (2020). Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells. Leukemia Research. 100. 106490–106490. 8 indexed citations

Leenders, Ruben G.G., M. van Sande, Daniel S. Müller, et al.. (2019). Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2. Bioorganic & Medicinal Chemistry Letters. 29(17). 2516–2524. 3 indexed citations

Krauss, Ramona, Florence F. Wagner, Bianca Dietrich, et al.. (2011). 1251 POSTER Preclinical and Clinical Development of 4SC-203 – a Novel Multi-target Kinase Inhibitor. European Journal of Cancer. 47. S160–S160. 2 indexed citations

Tasler, Stefan, Oliver Müller, Thomas Herz, et al.. (2009). Substituted 2-arylbenzothiazoles as kinase inhibitors: Hit-to-lead optimization. Bioorganic & Medicinal Chemistry. 17(18). 6728–6737. 34 indexed citations

10.

Ehlert, Jan E., et al.. (2004). Identification and Partial Characterization of a Variant of Human CXCR3 Generated by Posttranscriptional Exon Skipping. The Journal of Immunology. 173(10). 6234–6240. 112 indexed citations

11.

Ehlert, Jan E. & Michael H.G. Kubbutat. (2001). Apoptosis and Its Relevance in Cancer Therapy. Oncology Research and Treatment. 24(5). 433–440. 16 indexed citations

12.

Ludwig, Andreas, Jan E. Ehlert, Hans‐Dieter Flad, & Ernst Brandt. (2000). Identification of Distinct Surface-Expressed and Intracellular CXC-Chemokine Receptor 2 Glycoforms in Neutrophils: N -Glycosylation Is Essential for Maintenance of Receptor Surface Expression. The Journal of Immunology. 165(2). 1044–1052. 57 indexed citations

13.

Addison, Christina, Thomas O. Daniel, Marie D. Burdick, et al.. (2000). The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity. The Journal of Immunology. 165(9). 5269–5277. 488 indexed citations

14.

Ehlert, Jan E.. (2000). Chemokines and Chemokine receptors: disease targets for therapeutic development. Expert Opinion on Investigational Drugs. 9(3). 627–629.

15.

Stoeckelhuber, Mechthild, Petra Baumgärtner, Jan E. Ehlert, et al.. (2000). Stimulation of Cellular Sphingomyelin Import by the Chemokine Connective Tissue-activating Peptide III. Journal of Biological Chemistry. 275(48). 37365–37372. 8 indexed citations

16.

Krijgsveld, Jeroen, Sebastian A. J. Zaat, Jan Meeldijk, et al.. (2000). Thrombocidins, Microbicidal Proteins from Human Blood Platelets, Are C-terminal Deletion Products of CXC Chemokines. Journal of Biological Chemistry. 275(27). 20374–20381. 277 indexed citations

17.

Belperio, John A., Michael P. Keane, Douglas A. Arenberg, et al.. (2000). CXC chemokines in angiogenesis. Journal of Leukocyte Biology. 68(1). 1–8. 655 indexed citations breakdown →

18.

Strieter, Robert M., Christina Addison, Jan E. Ehlert, et al.. (1999). Use of Immunodeficient Mice for the Evaluation of CXC Chemokines in the Regulation of Tumor-associated Angiogenesis. ILAR Journal. 40(4). 175–182. 5 indexed citations

19.

Ehlert, Jan E., Frank Petersen, Michael H.G. Kubbutat, et al.. (1995). Limited and Defined Truncation at the C Terminus Enhances Receptor Binding and Degranulation Activity of the Neutrophil-activating Peptide 2 (NAP-2). Journal of Biological Chemistry. 270(11). 6338–6344. 23 indexed citations

20.

Theologides, Athanasios, Jan E. Ehlert, & B. J. Kennedy. (1976). The calorie intake of patients with advanced cancer.. PubMed. 59(8). 526–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact